Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Prepaid Assets (2016 - 2025)

Amicus Therapeutics filings provide 16 years of Prepaid Assets readings, the most recent being $38.5 million for Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 10.32% to $38.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $38.5 million, a 10.32% increase, with the full-year FY2025 number at $38.5 million, up 10.32% from a year prior.
  • Prepaid Assets hit $38.5 million in Q4 2025 for Amicus Therapeutics, roughly flat from $38.5 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $54.4 million in Q1 2024 to a low of $20.1 million in Q3 2021.
  • Median Prepaid Assets over the past 5 years was $37.8 million (2022), compared with a mean of $38.1 million.
  • Biggest five-year swings in Prepaid Assets: skyrocketed 90.55% in 2022 and later tumbled 32.99% in 2024.
  • Amicus Therapeutics' Prepaid Assets stood at $34.8 million in 2021, then grew by 15.38% to $40.2 million in 2022, then grew by 23.19% to $49.5 million in 2023, then dropped by 29.52% to $34.9 million in 2024, then rose by 10.32% to $38.5 million in 2025.
  • The last three reported values for Prepaid Assets were $38.5 million (Q4 2025), $38.5 million (Q3 2025), and $46.3 million (Q2 2025) per Business Quant data.